Harvard Bioscience to acquire GNSL

Research tool developer HBIO will acquire Genomic Solutions (GNSL) for 3.2 million shares of HBIO and $9 million in cash, valuing the deal at $28 million based on HBIO's Thursday close at $5.95. HBIO ...